Theme: Exploring the challenges concerning excellence in dementia research and care

Vascular Dementia 2017

Vascular Dementia 2017

Conference series LLC organizes conference series all around the world in 2017; here it is our pleasure to invite you to Neuroscience conference entitled 6th International Conference on Vascular Dementia during February 27th - March 01st, 2017 at Amsterdam, Netherlands.

Attendance at this meeting will enable you to:

  • Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases like Dementia and Alzheimer's Diseases

  • Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field

  • Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.

  • Network with speakers and other leading experts across disciplines.

Vascular dementia, also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), is dementia caused by problems in the supply of blood to the brain, typically a series of minor strokes, leading to worsening cognitive decline that occurs step by step.

The term refers to a syndrome consisting of a complex interaction of cerebrovascular disease and risk factors that lead to changes in the brain structures due to strokes and lesions, and resulting changes in cognition. The temporal relationship between a stroke and cognitive deficits is needed to make the diagnosis.

Track 1 Dementia

Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer's is the most common type of dementia.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 2 Causes and Prevention

Dementia is caused by damage to brain cells. This damage interferes with the ability of brain cells to communicate with each other. When brain cells cannot communicate normally, thinking, behavior and feelings can be affected.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 3 Vascular Dementia

Vascular dementia is defined as inadequate blood flow can damage and eventually kill cells anywhere in the body. In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy bodies. Vascular dementia symptoms may be most obvious when they happen soon after a major stroke includes confusion, disorientation, trouble speaking or understanding speech and vision loss.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 4 Ageing and Dementia

Almost 40 per cent of people over the age of 65 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as "age-associated memory impairment," which is considered a part of the normal aging process.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 5 Advances in Dementia Test

A range of tests and diagnostic procedures is needed to diagnose dementia, but there are several that are fairly commonly used to diagnose dementia. These tests for dementia are mainly tests of mental abilities, blood tests and brain scans. Tests can help the doctor learn whether dementia is caused by a treatable condition. Even for those dementias that cannot be reversed, knowing the type of dementia a person has can help the doctor prescribe medicines or other treatments that may improve mood and behavior and help the family.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 6 Dementia Stages

Progressive dementia, which is dementia that gets worse with time, is the most common type. Five stages of progressive dementia have been outlined. They are part of the Clinical Dementia Rating (CDR), which professionals use to evaluate the progression of symptoms in patients with dementia. The five stages describe a patient’s ability to perform in six different areas of cognition and functioning: orientation, memory, judgment, home and hobbies, personal care, and community. The stages include early dementia, Moderate dementia, Advanced dementia, Test of dementia stages, Advances in research of dementia stages.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 7  Dementia Care Management

Alzheimer's disease and other types of dementia can be a challenging journey, not only for the person diagnosed but also for their family members and loved ones. Caring for someone with Alzheimer's or dementia can seem overwhelming at times, but the more information and support you have, the better you can navigate the demanding road ahead and determine the long-term care options that are best suited to you and your loved one. There are some Alzheimer’s care preparations that are best done sooner rather than later. It may be hard to consider these questions at first, as it means thinking about a time when your loved one is already well down the road of his or her Alzheimer’s journey.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 8 Vascular Dementia Nursing

Nursing is the protection, promotion, and optimization of health and abilities, prevention of illness and injury, facilitation of healing, alleviation of suffering through the diagnosis and treatment of human response, and advocacy in the care of individuals, families, groups, communities, and populations.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 9 Advanced Drug for Dementia

The mainstay of management of vascular dementia is the prevention of new strokes. This includes administering antiplatelet drugs and controlling major vascular risk factors. Neuroprotective drugs such as nimodipine, propentofylline, and posatirelin are currently under study and may be useful for vascular dementia. Omentum in the treatment of vascular dementia. The sub tracks includes Cholinisterase inhibitors, Impact of treatment with N-Acetylcysteine, Oral redox polymer therapeutics, Snoezellen and Multi sensory stimulation, Effect of thioctic and enantiomers, Role of phospholipids, Effects of brain afobazole.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 10 Potential Future Interventions

National Plan to Address Alzheimer’s Disease, a national effort to expand research in Alzheimer’s and related dementias prevention and treatment and to move the most promising drugs from discovery into clinical trials.

The Plan aims to prevent and effectively treat Alzheimer’s and related dementias by 2025. Its foundation is the 2011 National Alzheimer’s Project Act (NAPA), which was developed to create and maintain a national strategy to overcome the disease.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 11 Neuro-entrepreneurship: Vascular Dementia

Brain is an intangible conundrum which buries millions and millions of memories.

Entrepreneurship is the process of designing a new business, i.e. a startup company offering a product, process or service.

We are convinced that these new approaches to entrepreneurship research will have high impact and will lead to some of the most exciting and best publications in the years to come.

Bringing these new approaches together in one track will provide a forum for some of the best scholars in the field to join Vascular Dementia Conference 2017 and it will provide the audience with a look into the future of entrepreneurship research.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 

Track 12 Animal Models and Translational Medicine

Animal models for Alzheimer’s disease it is important to think about the human phenotype and what is being modeled in terms of the animal phenotype. The moderator, Bradley Hyman, professor of neurology at Harvard Medical School, said that animal models of Alzheimer’s disease, based on the genetics of the disease and the closely related front temporal dementia, replicate at least some of the pathology. Researchers have been successful at modeling very specific aspects of Alzheimer’s disease in the mouse (e.g., plaques, tangles). Although these are incomplete models of the human disease, they have been well received in the field as potentially relevant models for use in drug discovery.

Related Alzheimer's Conferences | Vascular Dementia Conferences | Dementia Conferences | Neurology Conference

11th World Congress on Neurology and Therapeutics March 27-29, 2017 Madrid, Spain; 2nd International Conference on Spine and Spinal Disorders July 24-26, 2017 Rome, Italy; 3rd International Conference on Spinal Surgery April 17-19, 2017 Zurich, Switzerland; 3rd International Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 2nd International Conference on Neuro Oncology and Brain Tumor April 24-25, 2017 Dubai, UAE; 2nd International conference on Osteoporosis & Musculoskeletal Disorders May 22-24, 2017 Mexico, USA; 2nd International Conference on Neuro Rehabilitation May 25-26, 2017 Chicago , USA; 7th International Conference on Dementia & Care Practise May 29-31, 2017 Toronto, Canada; 2nd International Conference and Exhibition on Dual Diagnosis May 29-30, 2017 Munich, Germany; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, The Netherlands; 13th International Conference on Child Neurologists August 06-07, 2017 Birmingham, UK; BlazeSports America and Bluefield Project to Cure Frontotemporal DementiaLewy Body Dementia Association and LGS FoundationAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery FoundationAlzheimer's Association and Alzheimer's Foundation of AmericaJain Foundation and John Douglas French Alzheimer's Foundation

 



 

Conference series LLC invites all the participants from all over the world to attend 6th International Conference on Vascular Dementia during February 27th - March 01st, 2017 at Amsterdam, Netherlands with the Theme: Exploring the challenges concerning excellence in dementia research and care which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Vascular dementia is defined as inadequate blood flow can damage and eventually kill cells anywhere in the body.

In vascular dementia, changes in thinking skills sometimes occur suddenly following strokes that block major brain blood vessels. Vascular brain changes often coexist with changes linked to other types of dementia, including Alzheimer's disease and dementia with Lewy bodies. Vascular dementia symptoms may be most obvious when they happen soon after a major stroke includes confusion, disorientation, trouble speaking or understanding speech and vision loss.

Vascular dementia is the second-most-common type of dementia in the United States and Europe in the elderly, however it is the most common form in some parts of Asia. The incidence of the illness is 1.5% in Western countries and just about 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. The prevalence of dementia is 9 times higher in patients who have had a stroke than in controls. 25% of stroke patients develop new-onset dementia within 1 year of their stroke. The relative risk of incident dementia is 5.5% within 4 years of suffering a stroke.

The overall multi infarct dementia market is segmented into North America, Asia Pacific, Europe, Latin America and MEA. As of 2014, North America held largest market share in terms of revenue owing to the increasing incidences of multi infarct dementia coupled with increasing geriatric population base. European market displayed similar traits and followed North American multi infarct dementia market. Asia Pacific is expected to grow at a high pace due to increasing awareness about prevention of brain strokes in this region. Japan owing to increased geriatric base represents approximately more than 50% of the dementia cases in Asia Pacific. The developed nations such as Japan, Canada, France, Germany and U.S. are anticipated to witness favourable growth over the forecast period.

Various companies in the multi infarct dementia market are adopting several economical strategies such as collaborations, expansions and acquisitions to keep a strong position and gain advantage in the market. Some major companies in the market include Forest Laboratories, Inc., Janssen Pharmaceuticals, Inc., Novartis Pharmaceutical Corporation, Pfizer, Inc. and Eisai, Inc.

Why to attend ?

Vascular Dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

Target Audience

Business delegates, Industrial Leaders, Vascular Dementia Researchers, Neurologist, Neuroscientist, Neurosurgeons, CEO's and R&D Heads  from Industries, Directors, Psychiatrist, Nutritional Scientists, Head of department, Vascular Dementia Coach, Professors and Students from Academia in the research of vascular dementia.

Vascular Dementia 2017 welcomes attendees, presenters, and exhibitors from all over the world to Amsterdam, Netherlands. We are delighted to invite you all to attend and register for the 6th International Conference on Vascular Dementia during February 27th - March 01st, 2017 at Amsterdam, Netherlands

The organizing committee is gearing up for an exciting and informative   program on a variety of topics, poster presentations and various programs for participants from all over the world. Unsurpassed substantiation cure for Vascular Dementia clearly shows that the close association of families and carers in the care of their loved ones is key to improving early revealing of Vascular Dementia, renewal to a healthy   weight and sustaining long term wellbeing.

This conference will increase knowledge, provide support, assist learning and allow families and carers to seek out applicable services for their loved one and to develop the best possible home environment to support recovery from these complex and devastating diseases.

Vascular dementia, also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), is dementia caused by problems in the supply of blood to the brain, typically by a series of minor strokes. Vascular dementia is the second-most-common form of dementia after Alzheimer's disease (AD) in older adults. Vascular dementia is thought to be irreversible and it is caused by a number of small strokes or sometimes a large stroke preceded or followed by other smaller strokes. The term refers to a group of syndromes caused by different mechanisms all resulting in vascular lesions in the brain. Early detection and accurate diagnosis are important, as vascular dementia is at least partially preventable.

Globally, results of a recent meta-analysis suggest that 44 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 per cent of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63 per cent in 2030 and 71 per cent in 2050.This number is expected to double by 2030 and more than triple by 2050 to 115 million.

In the United States alone, experts estimate that as many as five million people age 65 and older suffer from Alzheimer’s disease

Dementia is widely considered the second most common cause of dementia after Alzheimer's disease, accounting for 10 per cent of cases. Many experts believe that vascular dementia remains underdiagnosed like Alzheimer's disease even though it's recognized as common.

Alzheimer's Research UK currently funds 150 research projects across the UK and has committed nearly £40million to dementia research.

Their research will focus on improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.

The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects.

Research conducted by the Alzheimer's Society, shows that there will be 850,000 people living with dementia in the UK by 2015. This will cost the UK £26 billion a year.

Two-thirds (£17.4 billion) of the cost of dementia is paid by people with dementia and their families, either in unpaid care (£11.6 billion) or in paying for private social care. This is in contrast to other conditions, such as heart disease and cancer, where the NHS provides care that is free at the point of use.

Vascular Dementia 2017 will be a platform where you will be sure to have a meaningful experience with scholars from around the world. All members of the Vascular Dementia 2017 organizing committee look forward to meeting you in Amsterdam, Netherland.

Our Conference will provide a perfect platform addressing:

• Laudable talks by the top-notch of the global scientific community

• Sterling workshop sessions

• Remarkable Awards and Global Recognition to meritorious Researchers

• Global Networking with 50+ Countries

• Novel Techniques to Benefit Your Research

• Global Business and Networking Opportunities

• Exquisite Platform for showcasing your products and International Sponsorship

See more at: http://vasculardementia.conferenceseries.com/

Importance and Scope

Vascular dementia Conference is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art research and technologies.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Vascular Dementia and its allied areas.

Why Amsterdam?

Amsterdam is the capital city and most populous city of the Kingdom of the Netherlands.

Its status as the Dutch capital is mandated by the Constitution though it is not the seat of the Dutch government, which is The Hague. As is the case in all the countries with the highest health care expenditures, the Netherlands has an exceptionally strong economy.

The country's GDP per capita was estimated at $41,711 in 2013, higher than all but a handful of OECD nations. The Dutch government paid the vast majority of health care costs, with nearly 86% of all spending coming from public sources in 2012, the highest proportion in the OECD.

Netherlands government allocate EUR 32.5 million to the fight against Neurological disease over the next four years. The Netherlands Organisation for Scientific Research (NWO) provided fund of €550 million to fuel the research on mental illness. NARSAD Young Investigator Grant provides $30,000 per year on research in Neural and behavior disorders such as schizophrenia, mood disorders, anxiety disorders, or child and adolescent mental illnesses.

Amsterdam is currently one of the best European cities in which to locate an international business. It is ranked fifth in this category and is only surpassed by London, Paris, Frankfurt and Barcelona. Many large corporations and banks have their headquarters in Amsterdam, including Akzo Nobel, Heineken International, ING Group, ABNAMRO, TomTom, Delta Lloyd Group and Philips. KPMG International's global headquarters is located in nearby Amstelveen, where many non-Dutch companies have settled as well, because surrounding communities allow full land ownership, contrary to Amsterdam's land-lease system.

Conference Highlights

  • Dementia

  • Causes and Prevention

  • Vascular Dementia

  • Ageing and Dementia

  • Advances in Dementia Test

  • Dementia Stages

  • Dementia Care Management

  • Vascular Dementia Nursing

  • Advanced Drug for Dementia

  • Potential Future Interventions

  • Neuro-entrepreneurship: Vascular Dementia

  • Animal Models and Translational Medicine

Funding Projects

  • Alzheimer’s Research UK

  • Alzheimer's Association

  • Alzheimer's Disease Education and Referral Center (ADEAR)

  • National Institute on Aging

  • Alzheimer's Foundation of America

  • Alzheimer’s Drug Discovery Foundation

  • Association for Frontotemporal Degeneration (AFTD)

  • BrightFocus Foundation

  • John Douglas French Alzheimer's Foundation

  • Lewy Body Dementia Association

  • National Institute of Mental Health (NIMH)

  • National Organization for Rare Disorders (NORD)

  • BRACE - Alzheimer's Research

  • Alzheimer's Society

  • Alzheimer's Society of Canada

Target Audience

  • Directors

  • Head of Department

  • Professors

  • Industrial

  • Neurologist

  • Neuroscientist

  • Neurosurgeons

  • Psychiatrist

  • Nutritional Scientists

  • Students from Academia in the research of Neurology, Nutrition

Around 55 associations of Vascular Dementia are there in Netherland.

  • Dutch Neurofederation

  • International Child Neurology Association

  • National Neurological Member Societies

  • European Federation of Neurological Associations

  • Netherlands Society for Neurosurgery

  • European Association of Neurosurgical Societies

  • Dutch Society of Child Neurology

  • The International Federation of Multiple Sclerosis Societies

  • Stroke Association

  • Brain Injury Rehabilitation Trust

  • National Neurological Member Societies

  • Alzheimer's Society

  • Migraine Trust

  • International Headache Society

  • Huntington's disease Association

  • Brain tumor organizations

  • National Brain Tumor Society

  • European Federation of neurological societies

  • The World Federation of Neurology

  • National Association for Mental Health  

Top universities 500 globally working in the field of Vascular Dementia.

  • Harvard University

  • University College London

  • University of California--San Francisco

  • Stanford University

  • Massachusetts Institute of Technology

  • Johns Hopkins University

  • University of California--Los Angeles

  • University of California--San Diego

  • Columbia University

  • University of Oxford

  • University of Cambridge

  • Yale University

  • University of Pennsylvania

  • University of Toronto

  • Washington University in St. Louis

  • New York University

  • McGill University

  • King's College London

  • Karolinska Institute

  • California Institute of Technology

There are around 200 universities in Netherland which are working in the field of Vascular Dementia.

  • Radboud University

  • Maastricht University, Faculty of Psychology and Neuroscience

  • University of Amsterdam

  • Leiden University

  • University College Utrecht

  • University of Groningen

  • Utrecht University

  • University Medical Center Groningen

  • VU University Amsterdam

  • Maastricht University

  • University Medical Center Utrecht

  • Leids University Medisch Centrum

Top Hospitals Associated with Vascular Dementia Research in World.

  • John Hopkins Medicine

  • Massachusetts General Hospital

  • Siloam Hospitals

  • Mayo Clinic

  • The Mount Sinai Hospital

  • Jefferson Hospital for Neuroscience

  • Neurology Florida Hospital

  • UNM Neurology Centre

  • Tampa General Hospital

  • Huntington Hospital

  • EI Camino Hospital

There are above 500 Companies Associated with Vascular Dementia Research in World.

  • Forest Laboratories

  • Janssen Pharmaceuticals

  • Novartis Pharmaceutical Corporation

  • Pfizer

  • Eisai

  • Actinogen Limited

  • Alector LLC

  • AlzProtect SAS

  • TauRx Therapeutics Ltd

  • Pacific Northwest Biotechnology

  • Tautatis Incorporated

References

http://www.rsc.org/chemistryworld/2014/07/asd

http://www.usnews.com/education/best-global-universities/neuroscience-behavior?page=2

http://www.thecompleteuniversityguide.co.uk/search/?q=amsterdam

http://www.brainandspine.org/neurological-centres-in-the-Netherlands

https://www.google.co.in/search?q=HOSPITALS+IN+UK&ie=utf-8&oe=utf-8&aq=t&rls=org.

http://en.wikipedia.org/wiki/List_of_pharmaceutical_manufacturers_in_the_Netherlands

http://www.iamexpat.nl/expat-page/healthcare/general-practitioners-gp-doctors-netherlands

http://www.grandviewresearch.com/industry-analysis/multi-infarct-dementia-market

http://www.transparencymarketresearch.com/multi-infarct-dementia-market.html

https://en.wikipedia.org/wiki/Vascular_dementia

Vascular Dementia 2016

Vascular Dementia 2016

The 4th International conference on Vascular Dementia (Vascular Dementia -2016) hosted by Conference Series LLC took place at Valencia, Spain during June 30th – July 2nd, 2016.

Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community.

Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2016 from Conference Series LLC.

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the three days event into the path of success with thought provoking keynote and plenary presentations highlighting the theme “Integrating Recent Discoveries and Interpreting Vascular Dementia Research for Better Health”

The conference proceedings were carried out through various Scientific-sessions, Plenary lectures, Workshop and Symposia of which the following topics were highlighted as Keynote-presentations: 

Conference Series LLC  has taken the privilege of felicitating Vascular Dementia 2016 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

Conference Series LLC , on behalf of the conference sponsor appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavours.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Vascular Dementia 2016 Conference.

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC “Journal of Alzheimer’s Disease & Parkinsonism” as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums.

We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Vascular Dementia 2016.

With the unique feedbacks from the conference, Conference Series LLC would like to announce the commencement of the 6th International Conference on Vascular Dementia during February 27th - March 01st, 2017 at Amsterdam, Netherlands

Let us meet again @ Vascular Dementia 2017


Past Reports  Gallery  

Key Topics

  • Dementia
  • Dementia Pathophysiology
  • Stroke-related Dementia
  • Sleep and Dementia
  • Young onset Dementia
  • Parkinson Dementia
  • Amyloid protein: A protein of great concern
  • Diabetes induced Dementia
  • Vascular Dementia prognosis
  • Senile Dementia
  • Cognitive impairment
  • Brain ageing and Dementia
  • Advances in Dementia Test
  • Neuroimaging
  • Advances in research of Dementia stages
  • Dementia Care Management
  • Social interventions in Dementia
  • Pediatric Dementia
  • Vascular Dementia Nursing
  • Advanced Drug for Dementia
  • Non pharmacological interventions in Dementia
  • Potential Future Interventions
  • Neuro-entrepreneurship: Vascular Dementia
  • Animal Models and Translational Medicine

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date February 27th - March 01st, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations